Looking forward to this meeting!

.@eaonc is hosting a webinar on EA1241, a companion study for pts previously enrolled in TAILORx or RxPONDER. Investigators & #ClinicalResearch professionals are invited to register below. 📅Feb 4 | 4 PM ET 🎙 @jsparano, @KalinskyKevin, @RimapatelMD 🔗bit.ly/EA1241webinar

Join me at the 43rd Annual Miami Breast Cancer Conference! I'll be sharing insights alongside top experts to advance breast cancer care. Use my last name discount code for FREE registration. Register today: gotoper.com/mbccfof #MBCC25 #BreastCancerCare #BCSM

#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD

#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD

From #ASH —> #SABCS25! Look forward to seeing how this is going to change/inform our practice in breast cancer!! In Person: Dec 10, 2025 ⏰ Time: 7-9PM ✅ Register here: bit.ly/aiosabcs25 #OncTwitter #MedTwitter #bcsm #AdvInOnc25 @OncUpdates @OncoAlert

Trial Activation: EA1241, led by @jsparano of @MountSinaiNYC, is a companion study for patients who previously took part in either the TAILORx or RxPONDER #BreastCancer trials. For more information: bit.ly/EA1241 cc: @KalinskyKevin, @RimapatelMD

Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi When considering de-escalation in HER2 early breast cancer, which factor most influences your decision?

Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi Are TIL levels currently influencing your treatment decisions in #TNBC in clinical practice? #breastcancer

In this episode of 5-Minute Journal Club, Dr Neil Love is joined by Dr Kevin Kalinsky to define the future role of TROP2-directed antibody-drug conjugates in breast cancer. Watch or listen here: ow.ly/5R5W50X4iy9

We kick-off the inaugural Atlanta Breast Cancer Conference with @KalinskyKevin welcoming attendees to discuss the care of multiple breast cancer subtypes. #AtlBreast25

Still time to register! Join our esteemmed faculty ⁦@EmoryUniversity ⁦@WinshipAtEmory⁩ Updates in #HNCA acrobat.adobe.com/id/urn:aai… on September 6th; ⁦@StokedStokes⁩ ⁦@NikkiSchmittMD⁩ ⁦@ConorSteuerMD⁩

Absolutely outstanding breast cancer session at #DDHO2025. Major themes included treatment de-escalation strategies, adjuvant advances making cure even more possible, and of course lifestyle guidance. I am so incredibly excited to join the remarkable team at @WinshipAtEmory

The Glenn Family Breast Cancer Center invites you to the Inaugural Atlanta Breast Cancer Conference on Saturday, September 27, 2025. Learn more and register at bioascend.com/atlanta-breast… #ATLBreast25

📅 Join us tomorrow for our, Expert Analysis of the Top Abstracts From the 2025 Oncology Meeting. We’re bringing timely, expert-led insights straight to your practice. ✅ Practical strategies for patient care ✅ Designed for oncologists and cancer care teams ✅ CME-accredited Don’t miss it—register now and be part of the conversation with, @FordePatrick, @KalinskyKevin, @stolaney1 Register: bit.ly/45H9vwt

Huge congratulations to @DrDawnHershman for receiving the Karnofsky award. Can’t think of a more deserving person. @ASCO

I am much looking forward to this! See you in Chicago.@WinshipAtEmory

Thank you Representative Williams for supporting #CancerResearch and addressing #drugshortages #priorauths so all #SurvivorsThrive @ASCO @WinshipAtEmory

Meaningful day on the Hill advocating for cancer research, improving access to care, and ending drug shortages w @wbaer5 @ASCO @WinshipAtEmory @EmoryUniversity #ASCOAdvocacySummit

Looking forward to advocating for our patients w cancer along w @wbaer5 @asco @WinshipAtEmory @EmoryUniversity #ASCOAdvocacySummit